Understand · Treat · Recover

Endoscopy, Biopsy and Diagnosis

Endoscopy allows the team to see the lining and collect tissue. The biopsy establishes the diagnosis and supports treatment planning.

For patients, families and caregivers worldwide. Approvals, access and care pathways vary by country. Evidence checked 21 October 2026.

This information is provided for general educational purposes and does not replace individualized medical advice. Diagnosis and treatment decisions should be made with a qualified healthcare team.

Chapter 5 of 20

What happens during endoscopy

A flexible camera passes through the mouth into the esophagus, stomach and first part of the small bowel. Local throat anaesthetic and/or sedation may be offered. Follow the unit’s fasting and escort instructions and tell staff about diabetes medicines, anticoagulants, allergies and previous sedation problems. Do not stop prescribed medicines without instructions. Biopsies are small samples taken through the scope; taking them does not generally spread cancer.

Why several samples matter

Multiple biopsies from a suspicious area improve the chance of identifying the tumour and provide tissue for biomarkers. A negative superficial biopsy does not always settle a suspicious thickening or nonhealing lesion. Repeat endoscopy, deeper sampling or endoscopic ultrasound-guided sampling may be considered. The endoscopist records the location, size and relationship to the GEJ because these affect staging and surgery.

Reading the pathology report

Look for the histological diagnosis, grade and any comment on poorly cohesive or signet-ring cells. Immunohistochemistry uses stains to identify proteins and can help distinguish adenocarcinoma from other cancers. HER2, MMR and other predictive tests may follow in a separate report. A biopsy usually cannot provide the full pathological stage: depth, nodes and margins often require resection or further assessment.

Dysplasia and premalignant changes

Dysplasia means abnormal precancerous cells and is graded by severity. Atrophy and intestinal metaplasia describe changes in background lining, not invasive cancer. Expert review, high-quality inspection and risk-based surveillance or endoscopic removal may be appropriate. The plan depends on whether a visible lesion exists, its grade, the extent of mucosal change and individual risk.

What endoscopic ultrasound adds

EUS combines endoscopy with ultrasound to assess wall layers and nearby nodes when that information could change management. It is not necessary before every endoscopic removal or for every already metastatic cancer. Keep copies of the endoscopy, biopsy and biomarker reports. Ask when results will be discussed and whom to contact if swallowing or intake worsens while waiting.

Key takeaways

A clear tissue diagnosis and adequate material for biomarkers prevent avoidable treatment uncertainty.

Frequently asked questions

Is a scan enough to diagnose adenocarcinoma?

Usually tissue confirmation is needed before cancer-specific systemic treatment.

Why repeat a biopsy?

The first sample may be too small, superficial or unsuitable for the tests needed.

Does biopsy show the complete stage?

Usually not; staging combines pathology, imaging and sometimes laparoscopy.

Is IHC the same as NGS?

No. IHC assesses proteins; NGS examines genetic alterations.

Is intestinal metaplasia cancer?

No. It is a background change that may increase risk and needs individual assessment.

What problems after endoscopy need help?

Severe chest or abdominal pain, fever, breathing difficulty, significant bleeding or persistent vomiting need urgent advice.

References and further reading